ARPA-H, FDA Explore Medical Imaging Data Marketplace

The Advanced Research Projects Agency for Health and the Food and Drug Administration’s Center for Devices and Radiological Health are planning to improve access to medical imaging data by setting up a new commercial platform.

Intended for entities seeking to train artificial intelligence and machine learning applications, the medical imaging data marketplace could make it easier and cheaper to acquire data derived from computed tomography, magnetic resonance imaging and other scan types, ARPA-H said.

Development is expected to include tools to improve customer confidence that accessed data adheres to future pre-market authorization requirements. ARPA-H Program Manager Ileana Hancu said the MIDM will “facilitate more streamlined regulatory approvals.”

For the initiative’s first phase, the agency plans to survey stakeholders on the new platform’s design.

On March 21, join the Potomac Officers Club’s 5th Annual AI Summit, where federal leaders and industry experts converge to explore the transformative power of artificial intelligence.